About this trial
This study examines the effectiveness of virtual reality (VR) protocols based on mindfulness as a nonpharmacological approach to reduce social anxiety among adolescents. Conducted as a non-randomized, controlled, multi-center trial, the research aims to provide evidence supporting the integration of VR mindfulness interventions into clinical practice to improve mental health and well-being among adolescents. The research focuses on adolescent patients aged 12 to 18 who present with anxiety-related symptoms. Each participant will undergo a single primary care consultation, during which they will experience a 15-20 minute VR session using the Healthy Mind® platform both before and after their clinical encounter. Participants will be screened with the Generalized Anxiety Disorder 7 (GAD-7) scale. To measure changes in anxiety levels, the State-Trait Anxiety Inventory (STAI) will be administered immediately before and after the VR sessions. This setup aims to assess the immediate impact of immersive VR on perceived anxiety in a real-world outpatient environment.
Eligibility criteria
Qualifiers
Adolescents aged 12-18 receiving care at the outpatient clinics of study locations
Patients with a GAD-7 score more than 5
Disqualifiers
Patients younger than 12 years old or older than 19 years old
Patients with a GAD-7 score lower than 5
Patient of legal age but subject to legal protection measures or unable to express their consent
Patients with dissociative psychiatric disorders
Trial design
Treatments tested in this trial
- Virtual reality
- Standard of care